PI3Kα-IN-12 (compound 13) is a highly selective PI3Kα inhibitor ( IC 50 : 1.2 nM). PI3Kα-IN-12 inhibits HCT-116 and U87-MG with IC 50 s values of 0.83 and 1.25 μM, respectively. PI3Kα-IN-12 (40 mg/kg; IP ) causes tumor regression in a U87-MG cell line xenograft mouse model.
Products | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PI3K
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.